Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double‐blind, randomized, nonpivotal, exploratory field study

BACKGROUND: The benefits of pimobendan in the treatment of congestive heart failure (CHF) in cats with hypertrophic cardiomyopathy (HCM) have not been evaluated prospectively. HYPOTHESIS/OBJECTIVES: To investigate the effects of pimobendan in cats with HCM and recent CHF and to identify possible end...

Descripción completa

Detalles Bibliográficos
Autores principales: Schober, Karsten E., Rush, John E., Luis Fuentes, Virginia, Glaus, Tony, Summerfield, Nuala J., Wright, Kathy, Lehmkuhl, Linda, Wess, Gerhard, Sayer, Margaret P., Loureiro, Joao, MacGregor, John, Mohren, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995419/
https://www.ncbi.nlm.nih.gov/pubmed/33543810
http://dx.doi.org/10.1111/jvim.16054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995419/
https://www.ncbi.nlm.nih.gov/pubmed/33543810
http://dx.doi.org/10.1111/jvim.16054

Ejemplares similares